Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis

Social Science and Medicine

Volumn 45, Issue 4, 1997, Pages 523-533

  Sloan, Frank A ^a   Whetten Goldstein, Kathryn ^a   Wilson, Alicia ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Cost containment; Cost effectiveness; Hospital pharmacies

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG UTILIZATION; HOSPITAL PHARMACY; LENGTH OF STAY; MANAGED CARE; MARKET; PUBLICATION;

COST CONTROL; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG UTILIZATION; DRUGS, GENERIC; FORMULARIES, HOSPITAL; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MANAGED CARE PROGRAMS; PHARMACY SERVICE, HOSPITAL; UNITED STATES;

EID: 0030758635     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0277-9536(96)00393-0     Document Type: Article

References (28)

1. Achusim, L. E. (1992) Therapeutic interchange as a cost-containment mechanism. PharmacoEconomics 2, 347.
2. American Society of Hospital Pharmacists (1992) ASHP technical assistance bulletin on assessing cost containment strategies for pharmacies in organized health care settings. American Journal of Hospital Pharmacy 49, 155.
3. Barriere, S. L. (1986) Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins. American Journal of Hospital Pharmacy 43, 625-629.
4. Bastean, B. (1995) Coordinator of PharmacoKenetics, Missouri Baptist Hospital. Telephone conversation 11/ 20/95.
5. Baumgardner, J. R. (1991) The interaction between forms of insurance contract and types of technical change in medical care. Rand Journal of Economics 22, 36.
6. Brown, G. R. and Clarke, A. M. (1992) Therapeutic interchange of cefazolin with metronidazole for cefoxitin. American Journal of Hospital Pharmacy 49, 1946.
7. Crane, V. S. (1993) How to use structured decision making in developing therapeutic, cost-effective formulary systems. Hospital Formulary 28, 859.
8. Drummond, M., Aristides, M., Davies, L. and Forbes, C. (1994) Economic evaluation of standard heparin and enoxaparin for prophylaxis against deep vein thrombosis in elective hip surgery. British Journal of Surgery 81, 1742.
9. Hospitals and Health Networks (1995) How markets evolve. Hospitals and Health Networks March 5.
10. Iglehart, J. K. (1993) Health policy report: the American health care system-managed care. New England Journal of Medicine 327, 742.
11. Kozma, C. M., Reeder, C. E. and Lingle, E. W. (1990) Expanding Medicaid drug formulary coverage: effects on utilization of related services. Medical Care 28, 963.
12. Lawrenz, C. A.. Cole, P., Theodorou, A., Cook, R. L. and Bermann, L. (1991) Therapeutic interchange of ampicillin-subactam for cefoxitin. American Journal of Hospital Pharmacy 48, 2150.
13. Luce, B.R. and Brown, R.E. (1995) The use of technology assessment by hospitals, health maintenance organizations, and third-party payers in the United States. International Journal of Technology Assessment in Health Care 11, 79.
14. Miller, R. H. and Luft, H. S. (1994) Managed care plan performance since 1980: a literature analysis. Journal of the American Medical Association 271(19), 1512.
15. Moore, W. J. and Newman, R. J. (1993) Drug formulary restrictions as a cost containment policy in medical programs. Journal of Law and Economics 36, 71.
16. Murray, D. (1995) The four market stages, and where you fit in. Medical Economics March 13, 44.
17. O'Brien, B. J., Anderson, D. R. and Coeree, R. (1994) Cost-effectiveness of enovaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Canadian Medical Association Journal 150, 1083.
18. Oh, T. and Franko, T. G. (1990) Implementing therapeutic interchange of intravenous famotidine for cimetidine and rantidine. American Journal of Hospital Pharmacy 47, 1547.
19. Pearce, M. J. and Begg, E. J. (1994) Hospital drug therapy cost containment through a preferred medicines list and drug utilization review system. New Zealand Medical Journal 107, 101.
20. Rascati, K. L. (1992) Survey of formulary system policies and procedures. American Journal of Hospital Pharmacy 49, 100.
21. Rich, D. S. (1989) Experience with a two-tiered therapeutic interchange policy. American Journal of Hospital Pharmacy 46, 1792.
22. Richardson, C. E. (1993) The ACE inhibitors. P & T January, 40.
23. 2-receptor antagonist use in 40 hospitals. Hospital Formulary 29, 379.
24. Sloan, F. A., Gordon, G. X. and Cocks, D. L. (1993) Hospital drug formularies and use of hospital services. Medical Care 31, 851.
25. Soumerai, S. B., Ross-Degnan, E., Avorn, J., McLauglin, T. J. and Choodnovskiy, I. (1991) Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. The New England Journal of Medicine 325, 1072.
26. Weisbrod, B. A. (1991) The health care quadrilemma: an essay on technological change, insurance, quality of care, and cost containment. Journal of Economic Literature 29, 523.
27. Wright, D. B. (1991) Antimicrobial formulary management: a case study in a teaching hospital. Pharmacotherapy Suppl. to 11, 27S.
28. Wunderlich, G. S., Sloan, F. A. and Davis, C. K. (eds) (1996). Nursing Staff in Hospitals and Nursing Homes: Is It Adequate? Institute of Medicine, National Academy Press, Washington, DC.